Correlation Between BB Biotech and UBS ETF

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and UBS ETF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and UBS ETF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and UBS ETF SMIM, you can compare the effects of market volatilities on BB Biotech and UBS ETF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of UBS ETF. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and UBS ETF.

Diversification Opportunities for BB Biotech and UBS ETF

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between BION and UBS is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and UBS ETF SMIM in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UBS ETF SMIM and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with UBS ETF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UBS ETF SMIM has no effect on the direction of BB Biotech i.e., BB Biotech and UBS ETF go up and down completely randomly.

Pair Corralation between BB Biotech and UBS ETF

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the UBS ETF. In addition to that, BB Biotech is 1.78 times more volatile than UBS ETF SMIM. It trades about -0.26 of its total potential returns per unit of risk. UBS ETF SMIM is currently generating about -0.01 per unit of volatility. If you would invest  26,605  in UBS ETF SMIM on September 12, 2024 and sell it today you would lose (60.00) from holding UBS ETF SMIM or give up 0.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  UBS ETF SMIM

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
UBS ETF SMIM 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UBS ETF SMIM has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, UBS ETF is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

BB Biotech and UBS ETF Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and UBS ETF

The main advantage of trading using opposite BB Biotech and UBS ETF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, UBS ETF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UBS ETF will offset losses from the drop in UBS ETF's long position.
The idea behind BB Biotech AG and UBS ETF SMIM pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency